Nanoform Finland Plc (NANOFH) - Total Liabilities
Based on the latest financial reports, Nanoform Finland Plc (NANOFH) has total liabilities worth €12.56 Million EUR (≈ $14.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see balance sheet size of Nanoform Finland Plc.
Nanoform Finland Plc - Total Liabilities Trend (2016–2024)
This chart illustrates how Nanoform Finland Plc's total liabilities have evolved over time, based on quarterly financial data. See NANOFH working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Nanoform Finland Plc Competitors by Total Liabilities
The table below lists competitors of Nanoform Finland Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KKB Engineering Berhad
KLSE:9466
|
Malaysia | RM376.97 Million |
|
Wellell Inc
TW:4106
|
Taiwan | NT$729.71 Million |
|
Y2 Solution Co., Ltd
KO:011690
|
Korea | ₩83.99 Billion |
|
Demco Public Company Limited
BK:DEMCO
|
Thailand | ฿2.35 Billion |
|
NICE Total Cash Management Co. Ltd
KQ:063570
|
Korea | ₩482.02 Billion |
|
Rekor Systems Inc
NASDAQ:REKR
|
USA | $44.03 Million |
|
Flexible Solutions International Inc
NYSE MKT:FSI
|
USA | $19.00 Million |
|
FELIX Gold Ltd
AU:FXG
|
Australia | AU$1.22 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Nanoform Finland Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check Nanoform Finland Plc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanoform Finland Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanoform Finland Plc (2016–2024)
The table below shows the annual total liabilities of Nanoform Finland Plc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €11.77 Million ≈ $13.77 Million |
+5.24% |
| 2023-12-31 | €11.19 Million ≈ $13.08 Million |
-16.69% |
| 2022-12-31 | €13.43 Million ≈ $15.70 Million |
-9.63% |
| 2021-12-31 | €14.86 Million ≈ $17.37 Million |
+32.07% |
| 2020-12-31 | €11.25 Million ≈ $13.15 Million |
+126.01% |
| 2019-12-31 | €4.98 Million ≈ $5.82 Million |
+56.78% |
| 2018-12-31 | €3.18 Million ≈ $3.71 Million |
+205.34% |
| 2017-12-31 | €1.04 Million ≈ $1.22 Million |
+82.31% |
| 2016-12-31 | €570.41K ≈ $666.87K |
-- |
About Nanoform Finland Plc
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) na… Read more